DLEXY yields 129.03% · JNJ yields 2.13%● Live data
📍 DLEXY pulled ahead of the other in Year 1
Combined, DLEXY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DLEXY + JNJ for your $10,000?
Datalex plc develops and sells various distribution and retailing software products and solutions to the airline industry in Ireland, the Americas, the Asia Pacific, the United Kingdom, and rest of European countries. The company operates in two segments, E-Business and TPF Consulting. It offers Datalex Direct, a customer-centric digital commerce product for travel retailing through airlines' direct channels; Datalex Merchandiser that enables airlines to deploy intelligent merchandising strategies across channels and touchpoints, generates ancillary revenue, and optimizes traveler engagement at various point in their journey; Datalex NDC, which provides end-to-end offer and order management for indirect channel using NDC; and Datalex Dynamic, which creates and optimizes capabilities by allowing airlines to build customer centric, contextualized, and personalized offers for air and non-air products. The company also provides Datalex China Shopping and Pricing Engine, an air shopping and pricing solution for Chinese airlines; and Datalex Pricing AI, a real-time pricing product. In addition, it delivers professional and hosting services; and offers online payment processing connectivity services, as well as IT consultancy services to airlines. Datalex plc was founded in 1985 and is headquartered in Dublin, Ireland.
Full DLEXY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.